# Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes

> **NCT07458269** · PHASE2 · RECRUITING · sponsor: **Kailera** · enrollment: 250 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** KAI-9531
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07458269
- **Lead sponsor:** Kailera
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-04
- **Primary completion:** 2027-05
- **Final completion:** 2027-06
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07458269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07458269, "Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07458269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*